Your browser doesn't support javascript.
loading
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs.
LeBlanc, Amy K; Mazcko, Christina N; Fan, Timothy M; Vail, David M; Flesner, Brian K; Bryan, Jeffrey N; Li, Shan; Wang, Feng; Harris, Scott; Vargas, Jesse D; Govindharajulu, Jeevan P; Jaganathan, Soumya; Tomaino, Francesca; Srivastava, Apurva K; Chou, Tsui-Fen; Stott, Gordon M; Covey, Joseph M; Mroczkowski, Barbara; Doroshow, James H.
Affiliation
  • LeBlanc AK; Comparative Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Mazcko CN; Comparative Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Fan TM; Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinosis.
  • Vail DM; Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinosis.
  • Flesner BK; Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin.
  • Bryan JN; Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri.
  • Li S; Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri.
  • Wang F; Comparative Oncology Radiobiology and Epigenetics Laboratory, University of Missouri, Columbia, Missouri.
  • Harris S; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.
  • Vargas JD; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.
  • Govindharajulu JP; Cleave Therapeutics Inc., San Francisco, California.
  • Jaganathan S; Cleave Therapeutics Inc., San Francisco, California.
  • Tomaino F; Clinical Pharmacodynamics Biomarker Program, ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland.
  • Srivastava AK; Clinical Pharmacodynamics Biomarker Program, ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland.
  • Chou TF; Clinical Pharmacodynamics Biomarker Program, ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland.
  • Stott GM; Clinical Pharmacodynamics Biomarker Program, ADRD, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland.
  • Covey JM; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.
  • Mroczkowski B; NExT Program Support, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Doroshow JH; Division of Cancer Diagnosis and Treatment and Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Mol Cancer Ther ; 21(10): 1510-1523, 2022 10 07.
Article in En | MEDLINE | ID: mdl-35876604
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Valosin Containing Protein / Lymphoma / Multiple Myeloma / Antineoplastic Agents Limits: Animals Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Valosin Containing Protein / Lymphoma / Multiple Myeloma / Antineoplastic Agents Limits: Animals Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article